| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |